We are live on ! Find out more
EIP

Epoch Investment Partners Portfolio holdings

AUM $16.5B
1-Year Est. Return 24.3%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+24.3%
3 Year Est. Return
+77.95%
5 Year Est. Return
+103.29%
10 Year Est. Return
+404.8%
AUM
$26.7B
AUM Growth
+$201M
Cap. Flow
-$334M
Cap. Flow %
-1.25%
Top 10 Hldgs %
19.71%
Holding
302
New
19
Increased
133
Reduced
125
Closed
21

Top Sells

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$147M
2
ABBV icon
AbbVie
ABBV
+$144M
3
TJX icon
TJX Companies
TJX
+$117M
4
AAPL icon
Apple
AAPL
+$102M
5
VOYA icon
Voya Financial
VOYA
+$87.4M

Sector Composition

Rank Sector Weight
1 Technology 15.82%
2 Healthcare 14.63%
3 Financials 11.32%
4 Industrials 10.42%
5 Utilities 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MO icon
26
Altria Group
MO
$113B
$313M 1.17%
4,538,289
+83,567
+2% +$5.35M
AMAT icon
27
Applied Materials
AMAT
$421B
$311M 1.17%
12,991,108
-156,719
-1% -$3.46M
BLK icon
28
Blackrock
BLK
$175B
$311M 1.17%
908,170
-6,776
-0.7% -$2.38M
TJX icon
29
TJX Companies
TJX
$178B
$310M 1.16%
8,028,684
-3,057,556
-28% -$117M
FIS icon
30
Fidelity National Information Services
FIS
$21.9B
$308M 1.16%
4,186,880
+1,957,224
+88% +$138M
RAI
31
DELISTED
Reynolds American Inc
RAI
$302M 1.13%
5,602,873
-75,470
-1% -$3.79M
MCK icon
32
McKesson
MCK
$101B
$294M 1.1%
1,574,862
-316,151
-17% -$55.5M
ETR icon
33
Entergy
ETR
$49.6B
$283M 1.06%
6,953,064
+104,232
+2% +$4M
DHR icon
34
Danaher
DHR
$140B
$281M 1.05%
4,141,895
-208,984
-5% -$13.7M
RDS.A
35
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$265M 0.99%
5,054,822
+88,549
+2% +$4.27M
CVS icon
36
CVS Health
CVS
$124B
$255M 0.96%
2,663,226
-771,233
-22% -$76.9M
AEE icon
37
Ameren
AEE
$29.9B
$249M 0.93%
4,641,757
+83,110
+2% +$4.09M
BA icon
38
Boeing
BA
$184B
$242M 0.91%
1,860,338
-70,568
-4% -$9.2M
MCD icon
39
McDonald's
MCD
$196B
$236M 0.89%
1,964,302
-34,996
-2% -$4.38M
LUMN icon
40
Lumen
LUMN
$6.06B
$236M 0.88%
8,122,025
+32,854
+0.4% +$957K
FFIV icon
41
F5
FFIV
$23.4B
$236M 0.88%
2,069,005
+558,464
+37% +$60M
AZN icon
42
AstraZeneca
AZN
$249B
$235M 0.88%
3,899,029
+47,814
+1% +$2.78M
AIG icon
43
American International
AIG
$42.3B
$229M 0.86%
4,329,379
-172,425
-4% -$9.52M
CXW icon
44
CoreCivic
CXW
$3.29B
$224M 0.84%
6,386,441
-119,598
-2% -$3.92M
SYF icon
45
Synchrony
SYF
$25.7B
$223M 0.84%
8,822,678
-5,050,627
-36% -$147M
SJM icon
46
J.M. Smucker
SJM
$12.7B
$220M 0.82%
1,442,706
-30,899
-2% -$4.11M
TEVA icon
47
Teva Pharmaceuticals
TEVA
$40.3B
$213M 0.8%
4,244,947
+212,090
+5% +$11.3M
DD icon
48
DuPont de Nemours
DD
$19.5B
$207M 0.78%
1,641,578
+25,182
+2% +$3.31M
DD
49
DELISTED
Du Pont De Nemours E I
DD
$202M 0.76%
3,111,321
-93,249
-3% -$6.12M
TT icon
50
Trane Technologies
TT
$106B
$201M 0.75%
3,158,738
-124,922
-4% -$8.04M

Similar funds

Epoch Investment Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Epoch Investment Partners held 302 positions worth $26.7B, up 0.76% from $26.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Epoch Investment Partners's Q2 2016 filing shows 19 new, 133 increased, 125 reduced and 21 closed positions. Its largest new stake was NextEra Energy: 4,841,632 shares worth $158M. The largest sale was Synchrony, an estimated $147M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Epoch Investment Partners's largest Q2 2016 buy was NextEra Energy: 4,841,632 shares worth $158M.
  • Epoch Investment Partners added most to Allergan plc in Q2 2016, an estimated $168M increase.
  • Epoch Investment Partners's biggest Q2 2016 reduction was Synchrony, cutting an estimated $147M.
  • Epoch Investment Partners fully exited Voya Financial in Q2 2016, selling an estimated $87.4M.
  • Epoch Investment Partners's ten largest holdings make up 20% of its $26.7B portfolio in Q2 2016.
  • Epoch Investment Partners opened 19 new positions and closed 21 in Q2 2016.
  • Epoch Investment Partners's portfolio value rose 0.76% quarter-over-quarter to $26.7B.

Based on Epoch Investment Partners's 13F filing for Q2 2016, filed 12 Aug 2016.